Edesa Biotech, Inc. (EDSA) — DEF 14A Filings
All DEF 14A filings from Edesa Biotech, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Edesa Biotech Proxy Statement Filed
— Apr 4, 2025 Risk: medium
Edesa Biotech, Inc. filed its Definitive Proxy Statement (DEF 14A) on April 4, 2025, for the fiscal year ending September 30, 2025. The filing details executive -
Edesa Biotech Announces 2024 Annual General and Special Meeting on May 30
— Apr 5, 2024 Risk: low
Edesa Biotech, Inc. (EDSA) filed a Proxy Statement (DEF 14A) with the SEC on April 5, 2024. Edesa Biotech, Inc. will hold its 2024 Annual General and Special Me
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX